A review of ramelteon in the treatment of sleep disorders
David N NeubauerDepartment of Psychiatry, Johns Hopkins University School of MedicineAbstract: Ramelteon is a selective melatonin receptor (MT1 and MT2) agonist that has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulty with sleep onset. I...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-03-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Online Access: | http://www.dovepress.com/a-review-of-ramelteon-in-the-treatment-of-sleep-disorders-a997 |